In our attempt to investigate the mechanism of the release of platelet-activating factor (PAF) from cells, the erythroleukemic cell line K562 was preloaded with a radiolabeled PAF analogue having an ethylcarbamyl residue, 1-O-octadecyl-2-O-ethylcarbamyl-sn-glycero-3-phosphocholine (ethylcarbamyl-PAF), that is resistant to the hydrolytic action of PAF acetylhydrolase. Its extracellular release was monitored using an albumin back-extraction method, and its metabolic degradation was analyzed by TLC. Phorbol myristate acetate (PMA) was found to stimulate the release of two radioactive lipids, ethylcarbamyl-PAF itself and its metabolite, 1-O-octadecyl-2-ethylcarbamyl-sn-glycerol, whereas only ethylcarbamyl-PAF was released from the resting cells. The increased release of radioactive lipids in PMA-stimulated cells was suggested to be due to stimulated degradation of intracellular ethylcarbamyl-PAF into the cell-permeable metabolite. Thus K562 cells have much less capacity to release intact PAF-like lipid in comparison with its high ability to uptake exogenously added PAF analogues previously described by us and others.
Dainippon Pharmaceutical (Osaka) and cultured in RPMI 1640 medium supplemented with 10% fetal calf serum, penicillin (100 U/ml), and streptomycin (100 mg/ml). Cells were maintained at 37°C in a humidified atmosphere containing 5% CO 2 in 95% air and subjected to passage every 3 d. Cells were harvested and washed twice with phosphate-buffered saline (PBS) and resuspended in fresh PBS for the experiments.
Preloading ]lyso-PAF for 60 min, the cells were incubated with PMA 0.1 mM, A23187 20 mM, or vehicle alone in the presence of 2% BSA that can trap the released lipids. At various time intervals, two 0.4-ml aliquots of the cell suspension were layered on 40 ml of a mixture of dibutyl phthalate and dinonyl phthalate (5 : 3, v/v) in a microcentrifuge tube as described previously.
16) The mixtures were promptly centrifuged at 10000ϫg for 1 min. The radioactivity of the supernatant, which was transferred carefully to into a scintillation vial containing 4 ml of Scintisol EX-H (Wako) together with the mixture of phthalates, was counted in a scintillation counter. The cell pellets were suspended twice in 100 ml of 1% Triton X-100, and the suspension was then transferred to vials containing 4 ml of Scintisol EX-H for measurement of radioactivity.
TLC Analysis of Metabolites Derived from [

H]Ethylcarbamyl-PAF and [
3 H]lyso-PAF For TLC analysis, 1-ml aliquots of cell suspensions were quickly centrifuged at 10000ϫg for 1 min. Lipids were extracted from both the supernatant and the pellet suspended in saline containing 0.1% BSA. Phospholipids were analyzed on silica gel 60 plates (E. Merck, Darmstadt, Germany) by TLC together with carrier levels of unlabeled PAF, lyso-PAF, ethylcarbamyl-PAF, phosphatidylcholine (PC), and phosphatidylethanolamine in a solvent system of chloroform/methanol/water (65 : 35 : 5, v/v/v). For separation of neutral lipids, a solvent system of nhexane/diethylether (1 : 2, v/v) was used. The silica gel in each lipid fraction was scraped off and its radioactivity was counted in 4 ml of Scintisol EX-H.
RESULTS AND DISCUSSION
Release of Ethylcarbamyl-PAF from K562 Cells To obtain insights on the mechanism of the release of PAF, we used [ 3 H]ethylcarbamyl-PAF as a metabolically stable mimetic of PAF, a long tail of which was linked to the glycerol backbone by an ether bond and a short tail of which was the carbamyl backbone. When K562 cells were incubated 3 H]ethylcarbamyl-PAF for 60 min at 37°C. At the end of the incubation period, K562 cells were centrifuged at 100ϫg for 2 min at 37°C and suspended in PBS. To extract radioactive lipids on the outer layer of the plasma membrane, the cell suspensions were further incubated in the presence of 2% BSA for 10 min and washed with fresh PBS two times to remove excess BSA. These cell suspension were then incubated with PMA 0.1 mM in the presence (᭡) or absence (᭝) of 2% BSA. For controls, the cells were incubated without PMA 0.1 mM in the presence (᭹) or absence (᭺) of 2% BSA. The amount of radioactivity associated with the cells was measured at 15, 30, and 60 min and expressed as a percentage of added radioactivity. Results are typical of two separate experiments. B) At 15, 30, and 60 min of incubation, the cell suspension was centrifuged, and radioactive lipids were extracted from the resultant supernatant and pellet fractions and analyzed by TLC as described under Materials and Methods. Results are typical of two separate experiments. The radioactivity of ethylcarbamyl-PAF ( ), octadecyl-acyl-G ( ), octadecyl-ethylcarbamyl-G ( ), and octadecyl-diacyl-G ( ) was counted. The values are expressed as percentages of the sum of radioactivities in the supernatant and pellet fractions. (Fig. 1A) , A23187 (data not shown), or vehicle alone (Fig. 1A) , and the percentage of radioactivity remaining in the cells was measured at 15, 30, and 60 min (Fig. 1A) as well as the percentage of the radioactivity released into the medium (data not shown). The percentage of radioactivity retained within the resting cells very slowly decreased with incubation time in the absence of 2% BSA, although the addition of 2% BSA significantly accelerated the externalization of the radioactive probe. While K562 cells appear able to internalize ethylcarbamyl-PAF effectively, its capability to externalize this probe appears to be very low under resting conditions. A greater time-dependent decrease in cell-associated radioactivity was observed with PMA-stimulated K562 cells in the presence of 2% BSA. Again, in the absence of 2% BSA, there was only slight decrease in the cell-associated radioactivity during the incubation. Similar results were obtained with A23187, although its stimulatory effect was less than that of PMA (data not shown). Our results with PMA are consistent with those reported by Bratton 20) who found that the release of radioactive lipid from polymorphonuclear leukocytes loaded with a [
3 H]PAF analogue with a methylcarbamyl group was stimulated with PMA, although Bratton showed no structural analysis of the released radioactive lipid. While PAF analogues with a methylcarbamyl or ethylcarbamyl group are believed to be metabolically very stable, we analyzed both the released and cell-associated radioactive lipids after incubation of [ 3 H]ethylcarbamyl-PAF-loaded K562 cells with PMA or vehicle. The radioactivity released from the unstimulated cells in the absence of 2% BSA was solely due to ethylcarbamyl-PAF (Fig. 1B, None) , whereas the radioactive lipids extracted by 2% BSA were ethylcarbamyl-PAF and its less polar metabolite (Fig. 1B, BSA) . The latter lipid was tentatively identified as 1-O-octadecyl-2-ethylcarbamyl-sn-glycerol (octadecyl-ethylcarbamyl-G) by cochromatography on a silica gel 60 plate with a standard prepared by hyrolysis of ethylcarbamyl-PAF with Bacilius cereus phospholipase C. The proportion of octadecylethylcarbamyl-G in the supernatant fraction was less than that of ethylcarbamyl-PAF, but increased gradually during the incubation. When K562 cells were stimulated with PMA in the absence of 2% BSA, similar proportions of octadecylethylcarbamyl-G were released with those from the unstimulated cells in the presence of 2% BSA, together with a minor amount of ethylcarbamyl-PAF (Fig. 1B, PMA) . We found that extracellular 2% BSA augmented the time-dependent release of octadecyl-ethylcarbamyl-G from the PMA-stimulated cells (Fig. 1B, BSAϩPMA) . The major radioactive lipid associated with unstimulated K562 cells was ethylcarbamyl-PAF (Fig. 1B, None and BSA) . The proportion of octadecyl-ethylcarbamyl-G was dramatically increased in the PMA-stimulated cells even at 15-min incubation with and without 2% BSA (Fig. 1B, PMA and BSAϩPMA). Minor amounts of two radioactive metabolites of ethylcarbamyl-PAF, 1-O-octadecyl-2-acyl-sn-glycero-3-phosphocholine (octadecyl-acyl-GPC) and 1-O-octadecyl-2,3-diacyl-sn-glycerol (octadecyl-diacyl-G) assigned from their chromatographic behavior on silica gel TLC plates, were also detected in these cell pellets. Our results indicate that PMA accelerated the apparent externalization rate of the radiolabeled probe via augmented degradation of ethylcarbamyl-PAF to octadecyl-ethylcarbamyl-G, which was presumed to be externalized more easily than ethylcarbamyl-PAF itself.
Effects of D609 and NaF on the Degradation of Ethylcarbamyl-PAF Our results suggest that the PMA-induced degradation of ethylcarbamyl-PAF to octadecyl-ethylcarbamyl-G is caused by PC-specific phospholipase C or the combined actions of phospholipase D and phosphatidic acid phosphohydrolase. First, we examined the effects of D609, a PC-specific phospholipase C inhibitor, but D609 did not affect the degradation of [ 3 H]ethylcarbamyl-PAF stimulated by PMA (Table 1) . If the ethylcarbamyl-PAF was metabolized by phospholipase D and phosphatidic acid phosphohydrolase, 1-O-octadecyl-2-O-ethylcarbamyl-sn-glycerol-3-phosphate must be detected after the inhibition of phosphatidic acid phosphohydrolase by NaF. However, we detected no significant amount of 1-O-octadecyl-2-ethylcarbamyl-sn-glycero-3-phosphate, even when the cells were pretreated with 15 mM NaF. While we could not characterize well the enzymes that are involved in the degradation of ethylcarbamyl-PAF, it should be mentioned that lysophospholipase C and D activities hydrolyzing alkyl ether-type lysophosphatidyl- 26 Vol. 27, No. 1 choline have been found in various rat tissue, [21] [22] [23] [24] rabbit kidney, 25) and Madin-Darby canine kidney cells. 26) Sawai et al. 27) reported that cloned putative neutral sphingomyleinase has phospholipase C-like activity on lyso-PAF in human embryonic kidney 293 cells.
Regulation of Externalization of Ethylcarbamyl-PAF and Its Metabolites Next, we examined the effects of various chemicals on the PMA-stimulated externalization of radioactive lipids from K562 cells prelabeled with [ 3 H]ethylcarbamyl-PAF (Table 2) . PMA-induced degradation of ethylcarbamyl-PAF in K562 cells does not appear to require the activation of protein kinase C, since both staurosporine and GF-109203X were found to have no effect on the PMA-induced degradation. Rapuano and Bockman 28) also reported that PMA activated a phospholipase C through a protein kinase C-independent mechanism, although the phospholipase was shown to hydrolyze phosphatidylethanolamine and phosphatidylinositol, but not PC. Neither W7 (inhibitor of calmodulin-dependent protein kinase) nor herbimycin A (inhibitor of tyrosine kinase) prevented the release of the radioactive lipid from the PMA-stimulated cells. NEM, a thiolalkylating reagent, markedly reduced the secretion of the radioactive probe up to 14% of the control, while DTT, a disulfide-reducing agent, did not inhibit the lipid release. However, the degradation of ethylcarbamyl-PAF and subsequent release of its metabolites were found to be independent of the intracellular depletion of ATP, since pretreatment of K562 cells with sodium azide plus 2-deoxyglucose (exhaustion of ATP) did not inhibit the externalization of radioactive lipids. Our results with quinine (inhibitor of exocytosis) suggest that an exocytotic process is not involved in the release of the PAF-like lipid and its metabolites. Bratton reported that the release of PAF analogue with the methylcarbamyl group from human neutrophils was inhibited by a transglutaminase inhibitor. 20) Several inhibitors of phospholipid transporter such as verapamil (P-glycoprotein inhibitor), spermine (phospholipid scramblase inhibitor), and monodansylcadaverine (transglutaminase inhibitor) were, however, inactive for the inhibition of the secretion of octadecyl-ethylcarbamyl-G. These results suggest that an unknown membrane protein other than the known floppase and scramblase may be responsible for the observed phenomenon.
Degradation of [ 3 H]Octadecyl-acyl-GPC in K562 Cells after Stimulation with PMA Previously, we reported that exogenously added [
3 H]lyso-PAF to polymorphonuclear leukocytes and platelets was internalized through the plasma membrane, transported to intracellular membranes, and converted to octadecyl-acyl-GPC there. 29) In agreement with the results of the previous study, we found that about 88% of cell-associated radioactivity was due to [ 3 H]octadecyl-acyl-GPC after 60 min of incubation of K562 cells with [ 3 H]lyso-PAF. After washing with PBS to remove unbound [ 3 H]lyso-PAF, the cells were stimulated with PMA in the presence of 2% BSA, and radioactive lipids that were present in both supernatants (BSA-extractable lipids) and pellets (BSA-unextractable lipids) were analyzed by TLC. About 4% of total radioactivity was due to octadecyl-acyl-GPC, a major lipid in the BSA-extractable fraction at 30 min (Fig. 2) . In addition, most of the radioactivity of the BSA-unextractable fraction was found to be attributed to [ 3 H]octadecyl-acyl-GPC, the January 2004 27 level of which decreased with incubation time. However, only small portions of its metabolites such as 1-O-alkyl-2-long chain acyl-G were released from the cells, probably due to their low cell-permeability.
In conclusion, K562 cells have high trapping ability for ethylcarbamyl-PAF, but their capacity to externalize the PAFlike lipid was very low. Although PMA stimulated the release of radioactive lipids from K562 cells loaded with [
3 H]ethylcarbamyl-PAF, it was found to be due to stimulated degradation of intracellular ethylcarbamyl-PAF into the cellpermeable metabolite.
